Selene Therapeutics Ltd. has identified brain permeable dihydroorotate dehydrogenase (DHODH) inhibitors reported to be useful for the treatment of epilepsy, cancer, Alzheimer’s disease, rheumatoid ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback